Norepinephrine Versus Ephedrine in Treatment of Hypotension During Spinal Anesthesia for Caesarean Section
NCT ID: NCT03163407
Last Updated: 2017-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
110 participants
INTERVENTIONAL
2016-07-01
2017-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Norepinephrine Versus Ephedrin for Prevention of Post Spinal Anesthesia in Cesarean Section
NCT03719625
Comparison of Norepinephrine and Ephedrine on Hypotension After Spinal Anesthesia in Parturients
NCT02542748
Ephedrine vs. Nor Epinephrine Infusion in Preventing Hypotension After Spinal Anesthesia for Cesarean Section
NCT02477501
Norepinephrine on Maternal Hypotension After Combined Lumbar and Epidural Anaesthesia
NCT06498115
Management of Postspinal Anesthesia Hypotension During Elective Cesarean Section: Baby Norepinephrine Versus Ephedrine
NCT06498076
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* GE group in which hypotension were managed using ephedrine increments of 6 mg Ephedrine every 3 min until correction of SBP
* GN group: patients of this group received 5mcg of Norepinephrine/3 min demographic and hemodynamic data of the two groups were compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Norepinephrine group
Treatment of the postspinal anesthesia hypotension by administrating 5 mcg of Norepinephrine intravenously every 3 min until normal systolic blood pressure
Norepinephrine
Treatment of the postspinal anesthesia hypotension by administrating 5 mcg of Norepinephrine intravenously every 3 min until normal systolic blood pressure
Ephedrine group
Management of the post spinal hypotension by administrating 6 mg of Ephedrine intravenously every 3 min
Ephedrine
Management of the post spinal hypotension by administrating 6 mg of Ephedrine intravenously every 3 min
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Norepinephrine
Treatment of the postspinal anesthesia hypotension by administrating 5 mcg of Norepinephrine intravenously every 3 min until normal systolic blood pressure
Ephedrine
Management of the post spinal hypotension by administrating 6 mg of Ephedrine intravenously every 3 min
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caesarean section under spinal anesthesia
* ASA status I or II
Exclusion Criteria
* Cardiac arrhythmia
18 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mongi Slim Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mhamed Sami Mebazaa
Professor, head of the anesthesia and ICU departement
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mongi Slim Hospital
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.